The efficacy of immunotherapy in bladder cancer (BCa) is highly influenced by tumor heterogeneity, underscoring the urgent need for mechanistic insights and precise molecular subtyping. Adenosine-to-inosine RNA editing (AIRE), a critical post-transcriptional mechanism driving…
Continue Reading
This study introduces a machine learning framework to predict effective antiviral combinations for influenza A. It identifies Pimodivir with Epinephrine or L-Adrenaline as synergistic agents, confirmed by experiments demonstrating increased binding affinity and viral…
Continue Reading
We developed a deep residual network (ResNet) framework to classify thyroid cancer differentiation states by integrating multiomic data and interpretability analysis. Our framework incorporated untargeted metabolomic, whole-exome sequencing, and transcriptomic data from 158 thyroid…
Continue Reading
Breast cancer is a leading cause of cancer-related mortality, with tumor heterogeneity and drug resistance posing significant challenges to treatment. We integrated single-cell RNA sequencing, spatial transcriptomics, and bulk RNA-seq deconvolution to analyze BRCA…
Continue Reading
Cancer research organization City of Hope has co-led a study to show that characterizing genetic material close to chromosomes predicts how mutated, cancer-causing genes reprogram DNA and alter the tumor microenvironment. City of Hope said…
Continue Reading
What You Should Know:
– Biostate AI, an innovator at the intersection of artificial intelligence and RNA sequencing raises $12M in Series A funding spearheaded by Accel, with participation from Gaingels, Mana Ventures, InfoEdge Ventures,…
Continue Reading
What You Should Know:
– Immunai, a leading AI biotech company specializing in mapping the human immune system and the Parker Institute for Cancer Immunotherapy (PICI), a collaborative consortium of the world’s leading immuno-oncology experts,…
Continue Reading
Drug design and development company Isomorphic Labs announced it raised $600 million dollars in its first external funding round.Thrive Capital led the round with participation from GV (Google Ventures) and existing investor Alphabet.
WHAT IT…
Building accurate prediction models and identifying predictive biomarkers for treatment response in Muscle-Invasive Bladder Cancer (MIBC) are essential for improving patient survival but remain challenging due to tumor heterogeneity, despite numerous related studies. To…
Continue Reading
Sai Bhamidipati, Pharmaceutical Regulatory Affairs Consultant
The biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases….
Continue Reading
